What is Brief History of Daicel Company?

Daicel Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

What is the history of Daicel?

Daicel Corporation began in 1919 as Dainippon Celluloid Company Limited, formed from the merger of eight celluloid manufacturers. This consolidation aimed to manage camphor tree resources and reduce market competition.

What is Brief History of Daicel Company?

The company's early focus was on integrated celluloid production, establishing a foundation for future diversification. This strategic beginning set the stage for its growth into a global chemical leader.

Daicel's journey from its 1919 origins to its current status as a diversified chemical manufacturer is a testament to its adaptability and innovation. The company has expanded its portfolio to include cellulose derivatives, plastics, and organic chemicals, impacting sectors from automotive to healthcare. For instance, its contributions to advanced materials are evident in various applications, and a deeper look at its market positioning can be found in a Daicel PESTEL Analysis. As of March 31, 2025, Daicel reported consolidated net sales of approximately ¥586.53 billion, underscoring its significant market presence.

What is the Daicel Founding Story?

Daicel Corporation's journey began on September 8, 1919, under the name Dainippon Celluloid Company. This significant establishment was not the creation of a single visionary but a strategic consolidation of eight regional celluloid manufacturers. This merger was a direct response to critical challenges plaguing the nascent celluloid industry, which was pioneering the world's first artificial plastic.

Icon

The Founding of Daicel Corporation

The genesis of Daicel Corporation, originally Dainippon Celluloid Company, was a pivotal moment in Japan's industrial history. Formed in 1919, it was a strategic alliance of eight regional celluloid manufacturers. This consolidation aimed to address intense market competition, the unsustainable harvesting of camphor trees—a crucial raw material—and to bolster the development of the celluloid processing sector.

  • Daicel Corporation history traces back to 1919.
  • The company was initially named Dainippon Celluloid Company.
  • It was formed by merging eight regional celluloid manufacturers.
  • The primary goal was to stabilize the industry and manage resources.

The initial business model of Dainippon Celluloid Company was centered on the production of celluloid, a material highly sought after globally for its versatility. This plastic, primarily composed of cellulose nitrate and camphor, represented a significant technological advancement. The company's formation was also a direct response to an environmental and economic crisis, highlighting an early awareness of resource management and industry stabilization. The collective funding from the merging entities was instrumental in navigating the early challenges of market saturation and raw material scarcity, setting a precedent for future growth and diversification. Understanding the Target Market of Daicel provides context for its early product focus.

Daicel SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

What Drove the Early Growth of Daicel?

The early history of Daicel Company is marked by a strong focus on diversification and integrated production, beginning with the introduction of 'acetyloid' in 1929. This cellulose acetate plastic was developed as a safer alternative to traditional celluloid, showcasing an early commitment to innovation and material science.

Icon Early Diversification and Acetate Production

In 1933, Daicel made a strategic move to fully enter the cellulose acetate business, aiming for self-sufficiency by integrating raw material production like acetic acid from carbide. The establishment of the Arai Plant in 1935 was a key milestone, initiating the production of acetylene-base organic chemicals and solidifying the company's chemical manufacturing foundation.

Icon Expansion and Public Offering

Further expansion saw the Sakai Plant begin acetate filament manufacturing in 1938, and the Ohtake Plant was established for tri-acetyl cellulose (TAC) production. A significant event in the Daicel Corporation history was its public offering on the Tokyo Stock Exchange in 1949, marking a new phase of growth and accessibility.

Icon Key Production Milestones and Market Penetration

By 1953, the Aboshi Plant commenced TAC manufacturing for photographic film, becoming a crucial supplier. The success of cellulose acetate filters for tobacco in the United States led to their mass production in Japan by 1958, demonstrating Daicel's ability to adapt products to new markets and applications.

Icon Adapting to Petrochemical Growth and Internationalization

During Japan's economic boom, Daicel participated in the first petrochemical complex and established Dainippon Kasei Co., Ltd. in 1961. The Sakai Plant began ABS resin manufacturing, and the Kanzaki Plant launched its polypropylene film business. International expansion accelerated in the early 2000s, with acquisitions like Rhein Chemie in 2004 and the full acquisition of Polyplastics in 2020. Daicel's consolidated net sales reached ¥586.53 billion in the fiscal year ended March 31, 2025, a 5.1% increase year-on-year, reflecting its continued evolution and strategic positioning. Understanding the history of Daicel's innovations is key to appreciating its journey, aligning with its Mission, Vision & Core Values of Daicel.

Daicel PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

What are the key Milestones in Daicel history?

The Daicel Corporation history is marked by significant milestones and persistent challenges, showcasing a deep-seated commitment to innovation. Key achievements include the commercialization of chiral columns, essential for chiral pharmaceutical development, and pioneering a unique production method for peracetic acid synthetic glycerin. The establishment of Daicel Safety Systems Inc. underscored a focus on automotive safety with airbag inflator manufacturing. The company's intellectual property portfolio continues to grow, with recent patents in areas like filter units for gas generators and curable resin compositions, alongside advancements in nanodiamond technology. A notable sustainability effort was the 2021 launch of biodegradable plastics under its 'Green Solutions' initiative. In April 2025, Daicel strengthened its market position by acquiring the remaining 65% stake in Toyama Filter Tow Co., Ltd.

Year Milestone
2000 Established 'DAICEL Production Innovation' to enhance manufacturing efficiency.
2020 Evolved 'DAICEL Production Innovation' into the 'Autonomous Production System' integrating AI.
2021 Launched a new line of biodegradable plastics under the 'Green Solutions' initiative.
April 2025 Acquired the remaining 65% stake in Toyama Filter Tow Co., Ltd.
April 2025 Granted a patent for a filter unit for gas generators.
July 2025 Published an application for a curable resin composition.

Daicel has consistently driven innovation, notably with its groundbreaking chiral columns that are vital for pharmaceutical research and development. The company also pioneered a unique production method for peracetic acid synthetic glycerin, demonstrating its chemical engineering prowess.

Icon

Chiral Column Commercialization

Daicel commercialized chiral columns, which are indispensable tools for resolving optical isomers in the pharmaceutical industry.

Icon

Peracetic Acid Synthetic Glycerin

The company pioneered a unique production method for peracetic acid synthetic glycerin.

Icon

Automotive Safety Systems

Daicel Safety Systems Inc. was established to focus on manufacturing automobile airbag inflators, contributing to automotive safety.

Icon

Advanced Material Patents

Recent patents in 2025 cover gas generators, compounds with high solubility and excellent carrier mobility, and nanodiamond compositions.

Icon

Biodegradable Plastics Launch

In 2021, Daicel launched a new line of biodegradable plastics under its 'Green Solutions' initiative to promote circular economies.

Icon

Strategic Acquisition

The acquisition of the remaining 65% stake in Toyama Filter Tow Co., Ltd. in April 2025 consolidated Daicel's market standing.

Daicel has navigated significant challenges, including an explosion at its Sakai Plant and the economic impact of oil crises, which necessitated strategic pivots like adopting the methanol carbonylation process for acetic acid production. More recently, the company experienced financial headwinds, with a decline in operating and net profits for the fiscal year ending March 31, 2025, and a drop in net sales and profits in the first quarter of fiscal year 2026.

Icon

Plant Incident

The company faced a significant challenge with an explosion at its Sakai Plant in its operational history.

Icon

Economic Downturns

The oil crisis prompted a national project to commercialize acetic acid via methanol carbonylation, a strategic shift that proved crucial for the company's recovery.

Icon

Recent Financial Performance

For the fiscal year ending March 31, 2025, Daicel reported a 2.2% decrease in operating profit and an 11.4% drop in profit attributable to owners of the parent, despite increased net sales. The first quarter of fiscal year 2026 saw a 4.3% decrease in net sales and a 40.6% drop in profit attributable to owners of the parent.

Icon

Productivity Enhancement

To counter challenges and boost productivity, Daicel implemented 'DAICEL Production Innovation' in 2000, evolving it into the 'Autonomous Production System' by integrating AI in 2020.

Icon

Organizational Restructuring

The company shifted to an SBU system, emphasizing market-in and customer-in strategies to better respond to market demands.

Icon

Sustainability Goals

Daicel achieved a 50% reduction in greenhouse gas emissions from its operational baseline by 2023, surpassing its 2025 target, demonstrating a strong commitment to environmental responsibility. Understanding the history of Daicel's innovations is key to appreciating its resilience.

Daicel Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What is the Timeline of Key Events for Daicel?

The Daicel Corporation's history is a testament to its adaptability and innovation, beginning with its founding on September 8, 1919, as Dainippon Celluloid Company. This marked the consolidation of eight celluloid manufacturers, laying the groundwork for future expansion. The company's early years saw significant developments, including the creation of 'acetyloid' in 1929, a safer alternative to traditional plastics, and a strategic decision in 1933 to integrate cellulose acetate production. Going public on the Tokyo Stock Exchange in 1949 was a major milestone, facilitating further growth and investment. The Aboshi Plant's commencement of tri-acetyl cellulose (TAC) production in 1953 for photographic film and the mass production of cellulose acetate filters for cigarettes in 1958 highlighted its expanding manufacturing capabilities. Participation in Japan's first petrochemical complex in 1961 further solidified its position in the industry. The company underwent name changes, becoming Daicel Co., Ltd. in 1966 and Daicel Chemical Industries, Ltd. in 1979, reflecting its evolving business scope. A significant technological achievement was the commercialization of chiral columns in 1982, a key innovation in separation technology. The establishment of 'DAICEL Production Innovation' in 2000 and the acquisition of U.S.-based Rhein Chemie in 2004 bolstered its specialty chemicals segment and global reach. The company celebrated its 100th anniversary in September 2019, a significant marker of its enduring legacy. The formulation of 'DAICEL VISION 4.0' and 'Accelerate 2025' in fiscal 2020 signaled a forward-looking strategy focused on digital transformation and sustainable growth, including the development of an 'Autonomous Production System' using AI. The launch of biodegradable plastics in 2021 under its 'Green Solutions' initiative underscores its commitment to environmental responsibility. The establishment of Daicel Medical Ltd. on October 2, 2023, signifies a strategic diversification into the healthcare sector.

Year Key Event
1919 Founded as Dainippon Celluloid Company, a merger of eight celluloid manufacturers.
1929 Developed 'acetyloid,' a less flammable acetate plastic.
1933 Decided to enter the cellulose acetate business with integrated production.
1949 Went public on the Tokyo Stock Exchange.
1953 Aboshi Plant began manufacturing tri-acetyl cellulose (TAC) for photographic film.
1958 Mass production of cellulose acetate filters for cigarettes began in Japan.
1961 Participated in Japan's first petrochemical complex.
1966 Company renamed Daicel Co., Ltd.
1979 Company renamed Daicel Chemical Industries, Ltd.
1982 Commercialized chiral columns.
2000 Established 'DAICEL Production Innovation'.
2004 Acquired U.S.-based Rhein Chemie, enhancing specialty chemicals.
2018 Established a joint venture with Olin Corporation.
2019 Celebrated its 100th anniversary.
2020 Formulated 'DAICEL VISION 4.0' and 'Accelerate 2025'; developed the 'Autonomous Production System' utilizing AI.
2021 Launched a new line of biodegradable plastics under its 'Green Solutions' initiative.
2023 Established Daicel Medical Ltd., specializing in the medical business.
2025 Production expansion plant for liquid crystal polymers (LCP) in Taiwan started operation.
2025 Reported consolidated net sales of ¥586.53 billion for the fiscal year ending March 31, 2025.
2025 Acquired the remaining 65% stake in Toyama Filter Tow Co., Ltd.
2025 Reported Q1 FY2026 net sales of ¥139.27 billion.
Icon Strategic Growth and Sustainability Goals

Daicel's future is guided by 'DAICEL VISION 4.0' and 'Accelerate 2025,' targeting significant growth and sustainability. The company aims to increase international sales to 40% of total revenue within three years.

Icon Financial Projections and Expansion Plans

For the fiscal year ending March 31, 2026, Daicel forecasts net sales of ¥600 billion. Expansion includes increasing sales volume for Engineering Plastics and automotive airbag inflators, with a new plant for Cycloolefin Copolymer (COC) set to boost sales by approximately 50%.

Icon Environmental Commitments

The company is committed to reducing greenhouse gas emissions by 30% by 2030 compared to 2018 levels. A key objective is sourcing 100% of its energy from renewable sources by 2030.

Icon Innovation and Value Creation

Daicel's trajectory emphasizes innovation in advanced materials and sustainable solutions. This aligns with its founding vision of 'making lives better by co-creating value,' a principle that has guided its Marketing Strategy of Daicel.

Daicel Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.